14,620 Views
•
08:29 min
•
October 02, 2014
DOI:
Summary
Automatically generated
Opgericht kanker cellijnen en xenograften hebben de steunpilaar van het onderzoek naar kanker in de afgelopen paar decennia. Echter, recente gegevens blijkt dat de therapeutische respons sterk wordt beïnvloed door de tumorcel micromilieu. Daarom hebben wij een ex vivo analyse van de primaire tumor specimens geneesmiddelontwikkeling doeleinden ontwikkeld.
Related Videos
07:16
Thermal Ablation for the Treatment of Abdominal Tumors
Related Videos
34144 Views
12:09
A Novel High-resolution In vivo Imaging Technique to Study the Dynamic Response of Intracranial Structures to Tumor Growth and Therapeutics
Related Videos
11374 Views
14:14
Adaptation of Semiautomated Circulating Tumor Cell (CTC) Assays for Clinical and Preclinical Research Applications
Related Videos
15768 Views
06:51
A Preclinical Murine Model of Hepatic Metastases
Related Videos
28225 Views
09:52
Isolated Hepatic Perfusion as a Treatment for Liver Metastases of Uveal Melanoma
Related Videos
13288 Views
09:24
Generation of Microtumors Using 3D Human Biogel Culture System and Patient-derived Glioblastoma Cells for Kinomic Profiling and Drug Response Testing
Related Videos
8974 Views
10:02
Assessment of Spontaneous Alternation, Novel Object Recognition and Limb Clasping in Transgenic Mouse Models of Amyloid-β and Tau Neuropathology
Related Videos
26299 Views
08:54
Treatment of Liver Metastases Using an Internal Target Volume Method for Stereotactic Body Radiotherapy
Related Videos
14010 Views
07:42
Contractions of Human-iPSC-derived Cardiomyocyte Syncytia Measured with a Ca-sensitive Fluorescent Dye in Temperature-controlled 384-well Plates
Related Videos
6130 Views
14:54
An In Vivo Method for Evaluating the Gut-Blood Barrier and Liver Metabolism of Microbiota Products
Related Videos
8303 Views
Read Article
Cite this Article
Corben, A. D., Uddin, M. M., Crawford, B., Farooq, M., Modi, S., Gerecitano, J., Chiosis, G., Alpaugh, M. L. Ex Vivo Treatment Response of Primary Tumors and/or Associated Metastases for Preclinical and Clinical Development of Therapeutics. J. Vis. Exp. (92), e52157, doi:10.3791/52157 (2014).
Copy